The role of PI3K/ AKT/mTOR pathway as the potential prognostic and predicitive factors in renal cell cancer patients treated with everolimus in the second and subsequent lines. Severe neurological symptoms in i patient with advanced renal cell carcinoma treated with sunitinib. Role of genetic variants in the PI3K/AKT/
